LivaNova (LIVN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LivaNova

    NASDAQ: LIVN · Real-Time Price · USD
    58.72
    0.40 (0.69%)
    At close: Sep 09, 2025, 3:59 PM
    58.72
    0.00%
    After-hours: Sep 09, 2025, 04:12 PM EDT

    LivaNova Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.25B 1.15B 1.02B 1.04B
    Cost of Revenue
    		 382.56M 382.3M 314.6M 329.4M
    Gross Profit
    		 870.87M 771.25M 707.2M 706M
    Operating Income
    		 129.05M -68.5M 52.7M -900K
    Interest Income
    		 30.07M 22.01M 4.7M 435K
    Pretax Income
    		 88.31M -81.23M -75.1M -124.5M
    Net Income
    		 63.23M 17.55M -86.2M -135.7M
    Selling & General & Admin
    		 526.26M 518.13M 469.2M 471.9M
    Research & Development
    		 182.51M 193.82M 155.8M 183.4M
    Other Expenses
    		 33.04M 131.6M 29.5M 51.5M
    Operating Expenses
    		 706.74M 843.55M 654.5M 706.8M
    Interest Expense
    		 63.07M 58.85M 48.3M 49.7M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 1.12B 1.22B 969.1M 1.04B
    Income Tax Expense
    		 25.06M -98.88M 11.1M 11.2M
    Shares Outstanding (Basic)
    		 54.24M 53.9M 53.47M 50.63M
    Shares Outstanding (Diluted)
    		 54.57M 54.21M 53.47M 50.63M
    EPS (Basic)
    		 1.17 0.33 -1.61 -2.68
    EPS (Diluted)
    		 1.16 0.32 -1.61 -2.68
    EBITDA
    		 202.52M 39.02M 30.85M -6.33M
    EBIT
    		 151.38M -21.84M -26.89M -74.32M
    Depreciation & Amortization
    		 51.14M 60.86M 57.8M 67.99M

    Add to Watchlist